Global Glycosidases Market, By Product (Enzymes, Instruments, Kits, Reagents), Application (Diagnostics, Drug Discovery and Development, Oncology, Immunology, Other Applications), End User (Academic Research Institutes, Pharmaceutical and Biotechnology Companies, Contract Research Organizations)– Industry Trends and Forecast to 2029
Market Analysis and Size
In recent years, several organisations have begun academic research to create new glycomics and glycobiology tools. Protein characterization procedures are advancing as a result of advances in chemical and biochemical research, such as high-performance liquid chromatography (HPLC) and Mass Spectrometry (MS). These techniques produce quick and highly sensitive results.
Data Bridge Market Research analyses that the glycosidases market is expected to reach the value of USD 139.93 million by the year 2029, at a CAGR of 11.3% during the forecast period. Glycosidases market is attaining a significant growth due to increasing research and development in glycomics.
Market Definition
Glycosidases are enzymes that aid in the formation of bonds in complex sugars as well as the degradation of biomass such as cellulose, hemicellulose, and starch. They are widely used in diagnostics, drug discovery and development, oncology, immunology, and other fields.
Glycosidases Market Dynamics
Drivers
-
Rising research and developments as well as high adoption of technology
Increasing investment in glycomic research, rising expenditure, and the adoption of advanced technology associated with glycomic instrumentation are some of the factors that will propel the glycosidases market during the forecast period of 2022-2029. On the other hand, increasing application from developing countries and emerging markets, as well as the need for biomarker identification and the growing use of personalised medicines, will create new opportunities for the growth of the glycosidases market during the forecast period.
-
The increase in the cost of operations and upsurge in academic researchs
Several organisations have begun academic research to create new glycomics and glycobiology tools. Protein characterization procedures are advancing as a result of advances in chemical and biochemical research, such as high-performance liquid chromatography (HPLC) and Mass Spectrometry (MS). These techniques produce quick and highly sensitive results. An increase in the demand for medicines to treat a variety of severe chronic diseases is also expected to fuel glycomics / glycobiology market growth.
Opportunities
On the other hand, increasing application from developing countries and emerging markets, as well as the need for biomarker identification and the growing use of personalised medicines, will create new opportunities for the growth of the glycosidases market during the forecast period.
Restraints/Challenges
Strict rules and regulatory framework, as well as time-consuming processes and a high degree of consolidation, act as a restraint factor for the growth of the glycosidases market during the forecast period.
This glycosidases market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the glycosidases market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Covid-19 Impact on Glycosidases Market
Hydroxychloroquine, a commonly used drug, has seen a dramatic increase in demand for the treatment of COVID-19. Because many developed countries are running low on these drugs, the high demand has created enormous opportunities for manufacturers of COVID-19 management drugs. The pharmaceutical and biotechnology industries are expected to grow significantly in the future due to the demand for COVID-19 vaccines and treatment drugs. COVID 19 is expected to have a significant impact on the glycosidases market as a result of these factors.
Recent Development
- Agilent Technologies (US) introduced the InfinityLab LC/MSD iQ System in June 2019.
- Thermo Fisher Scientific (US) introduced the UHMR Hybrid Quadrupole-Orbitrap Mass Spectrometer in June 2018.
Global Glycosidases Market Scope
The glycosidases market is segmented on the basis of product, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Enzymes
- Instruments
- Kits
- Reagents
Based on product, glycosidases market is segmented into enzymes, instruments, kits, reagents. Enzymes have been further sub-segmented into glycosidases, glycosyltransferases, neuraminidases, sialyltransferases and other glycomics enzymes. Instruments have been further segmented into antibody arrays, HPLC, lectin arrays, MALDI-TOF, mass spectrometers and other. Kits have been further segmented into glycan labeling kits, glycan purification kits, glycan release kits and other kits. Reagents have been further segmented into glycoproteins, monosaccharides, oligosaccharides and other reagents.
Application
- Diagnostics
- Drug Discovery And Development
- Oncology
- Immunology
- Other Applications
Based on applications, glycosidases market is segmented into diagnostics, drug discovery and development, oncology, immunology and other applications.
End User
- Academic Research Institutes
- Pharmaceutical And Biotechnology Companies
- Contract Research Organizations
Glycosidases market has also been segmented on the basis of end-user into academic research institutes, pharmaceutical and biotechnology companies and contract research organizations.
Glycosidases Market Regional Analysis/Insights
The glycosidases market is analysed and market size insights and trends are provided by country, product, application and end-user as referenced above.
The countries covered in the glycosidases market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
The global market is expected to be dominated by North America, followed by Europe. The largest share of North America is primarily due to rising glycomics research investments, rising RandD investments in pharmaceutical companies for drug discovery, and the presence of all key players.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The glycosidases market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for glycosidases market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the glycosidases market. The data is available for historic period 2010-2020.
Competitive Landscape and Glycosidases Market Share Analysis
The glycosidases market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to glycosidases market.
Some of the major players operating in the glycosidases market are Agilent Technologies, Inc., New England Biolabs (UK) Ltd., Thermo Fisher Scientific Inc., Merck KGaA,, Takara Bio Inc., Waters Corporation, Geno Technology Inc., USA., DH Tech. Dev. Pte. Ltd., Sumitomo Bakelite Co., Ltd., PerkinElmer Inc., Cambridge Isotope Laboratories, Inc., FUJIFILM Wako Pure Chemical Corporation, S-BIO, Vaupell Holdings Inc; RandD Systems, Inc., Bruker, Danaher., Shimadzu Analytical (India) Pvt. Ltd., RayBiotech, Inc., among others.
SKU-